• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞周期中多聚(ADP-核糖)的生理水平调节 HeLa 细胞的增殖。

Physiological levels of poly(ADP-ribose) during the cell cycle regulate HeLa cell proliferation.

机构信息

Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan.

Joint Research Center for Human Retrovirus Infection, Kagoshima University, Sakuragaoka 8-35-1, Kagoshima, 890-8544, Japan.

出版信息

Exp Cell Res. 2022 Aug 1;417(1):113163. doi: 10.1016/j.yexcr.2022.113163. Epub 2022 Apr 18.

DOI:10.1016/j.yexcr.2022.113163
PMID:35447104
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10009817/
Abstract

Protein targets of polyADP-ribosylation undergo covalent modification with high-molecular-weight, branched poly(ADP-ribose) (PAR) of lengths up to 200 or more ADP-ribose residues derived from NAD. PAR polymerase 1 (PARP1) is the most abundant and well-characterized enzyme involved in PAR biosynthesis. Extensive studies have been carried out to determine how polyADP-ribosylation (PARylation) regulates cell proliferation during cell cycle, with conflicting conclusions. Since significant activation of PARP1 occurs during cell lysis in vitro, we changed the standard method for cell lysis, and using our sensitive ELISA system, quantified without addition of a PAR glycohydrolase inhibitor and clarified that the PAR level is significantly higher in S phase than that in G1. Under normal condition in the absence of exogenous DNA-damaging agent, PAR turns over with a half-life of <40 s; consistent with significant decrease of NAD levels in S phase, which is rescued by PARP inhibitors, in line with the observed rapid turnover of PAR. PARP inhibitors delayed cell cycle in S phase and decreased cell proliferation. Our results underscore the importance of a suitable assay system to measure rapid PAR chain dynamics in living cells and aid our understanding of the function of PARylation during the cell cycle.

摘要

聚 ADP-核糖(PAR)的靶蛋白与来自 NAD 的长度高达 200 个或更多 ADP-核糖残基的高分子量、支链聚(ADP-核糖)(PAR)发生共价修饰。PAR 聚合酶 1(PARP1)是参与 PAR 生物合成的最丰富和研究最充分的酶。已经进行了广泛的研究来确定多 ADP-核糖基化(PARylation)如何在细胞周期中调节细胞增殖,得出的结论相互矛盾。由于 PARP1 在体外细胞裂解过程中会被显著激活,因此我们改变了细胞裂解的标准方法,并使用我们灵敏的 ELISA 系统进行定量,而无需添加 PAR 糖基水解酶抑制剂,并澄清 PAR 水平在 S 期明显高于 G1 期。在没有外源 DNA 损伤剂的正常条件下,PAR 的半衰期<40 s;与 S 期 NAD 水平的显著下降一致,PARP 抑制剂可挽救这一现象,与观察到的 PAR 快速周转一致。PARP 抑制剂延迟 S 期细胞周期并减少细胞增殖。我们的结果强调了合适的测定系统在测量活细胞中快速 PAR 链动力学方面的重要性,并有助于我们理解 PARylation 在细胞周期中的功能。

相似文献

1
Physiological levels of poly(ADP-ribose) during the cell cycle regulate HeLa cell proliferation.细胞周期中多聚(ADP-核糖)的生理水平调节 HeLa 细胞的增殖。
Exp Cell Res. 2022 Aug 1;417(1):113163. doi: 10.1016/j.yexcr.2022.113163. Epub 2022 Apr 18.
2
PARP enzyme de novo synthesis of protein-free poly(ADP-ribose).聚(ADP - 核糖)聚合酶(PARP)酶从头合成无蛋白质的聚(ADP - 核糖)。
Mol Cell. 2024 Dec 19;84(24):4758-4773.e6. doi: 10.1016/j.molcel.2024.10.024. Epub 2024 Nov 12.
3
An Enzyme-Linked Immunosorbent Assay to Quantify Poly (ADP-Ribose) Level In Vivo.一种用于体内定量聚(ADP - 核糖)水平的酶联免疫吸附测定法。
Methods Mol Biol. 2023;2609:91-100. doi: 10.1007/978-1-0716-2891-1_6.
4
Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.聚(ADP-核糖)聚合酶1和聚(ADP-核糖)在调节WRN和RECQL5活性中的差异作用与协同作用
Mol Cell Biol. 2015 Dec;35(23):3974-89. doi: 10.1128/MCB.00427-15. Epub 2015 Sep 21.
5
An enzyme-linked immunosorbent assay-based system for determining the physiological level of poly(ADP-ribose) in cultured cells.一种基于酶联免疫吸附测定的系统,用于测定培养细胞中聚(ADP-核糖)的生理水平。
Anal Biochem. 2016 Feb 1;494:76-81. doi: 10.1016/j.ab.2015.10.014. Epub 2015 Nov 6.
6
Poly(ADP-ribose) polymerase-1 affects vasopressin-mediated AQP2 expression in collecting duct cells of the kidney.聚(ADP-核糖)聚合酶 1 影响肾脏集合管细胞中血管加压素介导的水通道蛋白 2 的表达。
Am J Physiol Renal Physiol. 2024 Jan 1;326(1):F69-F85. doi: 10.1152/ajprenal.00144.2023. Epub 2023 Oct 19.
7
[Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].[聚(ADP-核糖)聚合酶1和2:经典功能以及与新的组蛋白聚(ADP-核糖基)化因子HPF1的相互作用]
Mol Biol (Mosk). 2023 Mar-Apr;57(2):254-268.
8
Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP‑ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells.单独抑制聚(ADP-核糖)聚合酶-1 或聚(ADP-核糖)糖水解酶,而不是联合抑制,可提高 HeLa 细胞的化疗疗效。
Int J Oncol. 2013 Feb;42(2):749-56. doi: 10.3892/ijo.2012.1740. Epub 2012 Dec 17.
9
Cell Cycle Resolved Measurements of Poly(ADP-Ribose) Formation and DNA Damage Signaling by Quantitative Image-Based Cytometry.通过基于图像的定量细胞术对聚(ADP - 核糖)形成和DNA损伤信号进行细胞周期分辨测量。
Methods Mol Biol. 2017;1608:57-68. doi: 10.1007/978-1-4939-6993-7_5.
10
Effect of mild temperature shift on poly(ADP-ribose) and γH2AX levels in cultured cells.温和温度变化对培养细胞中聚(ADP - 核糖)和γH2AX水平的影响。
Biochem Biophys Res Commun. 2016 Aug 5;476(4):594-599. doi: 10.1016/j.bbrc.2016.06.001. Epub 2016 Jun 2.

引用本文的文献

1
Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells.衰老与神经退行性变的病理生物化学:脑细胞中NAD+代谢的失调
Biomolecules. 2024 Dec 6;14(12):1556. doi: 10.3390/biom14121556.
2
PARP1 promotes EGFR-TKI drug-resistance via PI3K/AKT pathway in non-small-cell lung cancer.PARP1 通过 PI3K/AKT 通路促进非小细胞肺癌对 EGFR-TKI 药物的耐药性。
Cancer Chemother Pharmacol. 2024 Aug;94(2):209-221. doi: 10.1007/s00280-024-04668-2. Epub 2024 Apr 12.
3
Fluorescence-Based Analyses of Poly(ADP-Ribose) Length by Gel Electrophoresis, High-Performance Liquid Chromatography, and Capillary Electrophoresis.

本文引用的文献

1
Mechanistic insights into the three steps of poly(ADP-ribosylation) reversal.聚(ADP-核糖)水解逆转的三个步骤的机制见解。
Nat Commun. 2021 Jul 28;12(1):4581. doi: 10.1038/s41467-021-24723-3.
2
Poly(ADP-ribose) polymerase inhibition: past, present and future.聚(ADP-核糖)聚合酶抑制:过去、现在和未来。
Nat Rev Drug Discov. 2020 Oct;19(10):711-736. doi: 10.1038/s41573-020-0076-6. Epub 2020 Sep 3.
3
Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death.选择性小分子 PARG 抑制剂导致复制叉停滞和癌细胞死亡。
基于凝胶电泳、高效液相色谱和毛细管电泳的聚(ADP-核糖)长度的荧光分析。
Methods Mol Biol. 2023;2609:3-21. doi: 10.1007/978-1-0716-2891-1_1.
4
Emetine blocks DNA replication via proteosynthesis inhibition not by targeting Okazaki fragments.依米丁通过抑制蛋白质合成而不是针对冈崎片段来阻断 DNA 复制。
Life Sci Alliance. 2022 Sep 9;5(12):e202201560. doi: 10.26508/lsa.202201560.
Nat Commun. 2019 Dec 11;10(1):5654. doi: 10.1038/s41467-019-13508-4.
4
Targeting dePARylation selectively suppresses DNA repair-defective and PARP inhibitor-resistant malignancies.靶向去 PAR 化选择性抑制 DNA 修复缺陷和 PARP 抑制剂耐药的恶性肿瘤。
Sci Adv. 2019 Apr 10;5(4):eaav4340. doi: 10.1126/sciadv.aav4340. eCollection 2019 Apr.
5
DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors.DNA 复制脆弱性使卵巢癌细胞对聚(ADP-核糖)糖水解酶抑制剂敏感。
Cancer Cell. 2019 Mar 18;35(3):519-533.e8. doi: 10.1016/j.ccell.2019.02.004.
6
Interconnection between Metabolism and Cell Cycle in Cancer.癌症中代谢与细胞周期的相互联系
Trends Biochem Sci. 2019 Jun;44(6):490-501. doi: 10.1016/j.tibs.2018.12.007. Epub 2019 Jan 14.
7
PARP1-Erk synergism in proliferating cells.PARP1与Erk在增殖细胞中的协同作用。
Oncotarget. 2018 Jun 26;9(49):29140-29145. doi: 10.18632/oncotarget.25633.
8
The Importance of Poly(ADP-Ribose) Polymerase as a Sensor of Unligated Okazaki Fragments during DNA Replication.聚(ADP-核糖)聚合酶作为 DNA 复制过程中未连接的冈崎片段传感器的重要性。
Mol Cell. 2018 Jul 19;71(2):319-331.e3. doi: 10.1016/j.molcel.2018.06.004. Epub 2018 Jul 5.
9
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality.选择性缺失 PARG 可恢复 PAR 化并拮抗 PARP 抑制剂介导的合成致死性。
Cancer Cell. 2018 Jun 11;33(6):1078-1093.e12. doi: 10.1016/j.ccell.2018.05.008.
10
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.奥拉帕利治疗携种系 BRCA 突变的转移性乳腺癌患者。
N Engl J Med. 2017 Aug 10;377(6):523-533. doi: 10.1056/NEJMoa1706450. Epub 2017 Jun 4.